ICH Project

The Foundation participates in the International Conference on Harmonization of Pharmaceutical Regulations (ICH) and conducts activities to speed up and improve the efficiency of drug development through the creation of common guidelines. In addition, the Foundation will hold ICH immediate debriefing sessions and guideline briefing sessions, etc., and strive to disseminate information on ICH.

ICH is an abbreviation for International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
ICH is a joint initiative of drug regulatory authorities and representatives of the pharmaceutical industry. Since its establishment in 1990 and its reorganization on October 23, 2015, ICH has steadily evolved to respond to the globalization of drug development, regulation, and distribution, and the number of member organizations continues to increase.
The objectives of ICH are to ensure the timely and continuous availability of new medicines to patients, to avoid unnecessary duplication of human clinical trials, to ensure the efficient development, registration, and manufacture of safe, effective, and high-quality medicines, and to reduce animal testing without adversely affecting the assessment of safety and efficacy. To promote public health by facilitating international harmonization of technical requirements to reduce the use of animal studies without adversely affecting the assessment of safety and efficacy.

 ICH member

Announcements and Updates

ICH Project Content

Related Information

Share this page